⌘K

Login Start Free

Home/Filings/5/A/0001547522-16-000227

5/A//SEC Filing

OxySure Therapeutics, Inc. 5/A

Accession 0001547522-16-000227

CIK 0001413797operating

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 5:47 PM ET

Size

11.7 KB

Accession

0001547522-16-000227

Insider Transaction Report

Form 5/AAmended

Period: 2015-12-31

OxySure Therapeutics, Inc.OXYS

DirectorCEO, President, and Secretary10% Owner

Transactions

Award
Common stock
2015-12-31$0.20/sh+500,000$100,000→ 672,324 total
Award
Options (right to buy)
2015-12-31$0.20/sh+1,000,000$200,000→ 2,417,488 total
Exercise: $0.20From: 2016-01-01Exp: 2021-01-01→ Common stock (1,000,000 underlying)

Holdings

Options (right to buy)
Exercise: $0.25From: 2014-04-05Exp: 2019-12-05→ Common stock (1,417,488 underlying)
1,417,488
Common stock
172,324
Common stock
(indirect: By Trust)
400,000
Common stock
(indirect: Held by JTR Investments, Limited)
14,040,761

Footnotes (5)

[F1]Restricted stock units (RSUs) pursuant to employment agreement dated 1/1/2015.
[F2]Represents the earliest date(s) that any options became exercisable.
[F3]Represents the latest date(s) that any vested options expire.
[F4]Comprises vested options issued pursuant to various employment agreements and related amendments under the Company's 2004 Stock Option Plan.
[F5]Comprises options issuable pursuant to employment agreement dated 1/1/2015.

Documents

1 file

5
doc5.xml
PRIMARY DOCUMENT

Issuer

OxySure Therapeutics, Inc.

CIK 0001413797

Entity typeoperating

Related Parties

1

filerCIK 0001413797

Filing Metadata

Form type: 5/A
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 5:47 PM ET
Size: 11.7 KB

View on SEC.gov